BioTech Pharma Summit

🌟 We are delighted to announce that Dr. Marcus Jarman-Smith, Head of Marketing in Medical at Victrex, will be joining us as a speaker for RESCON Europe 2024 in Barcelona, Spain. 👨🔬 Dr Marcus Jarman-Smith is Head of Marketing in Medical at Victrex, working with PEEK-based materials and technology platforms to help solve complex design and engineering challenges. He has been working with PEEK, a high-performance polymer, since 2006 in various technical and commercial roles across industrial and medical markets. Dr Jarman-Smith’s specialist areas are medical implants, and pharmaceutical drug delivery applications. 📢 Dr Marcus Jarman-Smith will present the topic "PEEK polymers: a case study in soft mist inhaler innovation through material selection" 👉 Request the Brochure now at https://rescon-europe.com/ #RESCON24 #RESCONEUROPE #Inhalation #Respiratory #drugdelivery #polymers #SMI

🌟 Excited for RESCON Summit 2024 in Barcelona! 🌟 Our Head of Marketing, Marcus Jarman-Smith and I will join next week (27-28 June) industry pioneers at the RESCON Summit in Barcelona, where we'll delve into the future of Inhalation & Respiratory Drug Delivery and Connected Devices. This event is a unique opportunity to exchange insights and drive forward the innovations that are shaping our industry. In my recent post, I highlighted the crucial role of sustainability in our field. For those who missed it, sustainability remains central to our mission at Victrex. We are dedicated to developing solutions that advance healthcare while also supporting a sustainable future. At the summit, our goal is to foster meaningful dialogues with: 🔹 Design & Development Companies 🔹 Contract Development and Manufacturing Organizations (CDMOs) 🔹 Pharmaceutical Groups We aim to engage with their Design, Development, and Innovation teams to: 🔹 Explore the drivers behind material selection and qualification of PEEK polymers 🔹 Gather market insights & trends 🔹 Align our innovations with the evolving needs of the Drug Delivery devices industry 🚀 Why Victrex PEEK? Our PEEK polymers for Medical & Pharmaceutical applications are at the cutting edge of material science, offering exceptional performance in: 🔹 Inhalation Devices 🔹 Connected Devices 🔹 Respiratory Drug Delivery Systems And many more outside the field of respiratory devices. Beyond performance, our materials embody our commitment to sustainability and regulatory excellence, meeting rigorous standards (UPS 87, UPS 88, and USP 661.1). 🔍 Key Discussion Points: Innovation and Sustainability: How can we collectively drive sustainable innovation in drug delivery and connected devices? Material Selection Challenges: For those involved in material selection and manufacturing, what concerns might you have about adopting PEEK? How can we address these to unlock the full potential of this high-performance material? This summit is more than an opportunity to showcase products; it's a platform for visionary thinking and collaborative problem-solving. I'm looking forward to insightful discussions and new collaborations that will push the boundaries of our industry. 💬 Join the Conversation: Let's connect at #RESCON2024 and explore how we can shape the future of drug delivery together. #DrugDelivery #InhalationDevices #VictrexPEEK #RESCONSummit2024

🌟 We are delighted to announce that Andreas Meliniotis, VP of Device Development at Vectura Group, will be joining us as a speaker for RESCON Europe 2024 in Barcelona, Spain. 👨🔬 Andreas Meliniotis is VP of Device Development at Vectura and leads the engineering and device development group based in Cambridge, UK. With over 20 years’ experience at Vectura, he has led the design and development of several multidose dry powder inhalers as well as nebulisers and connected device technology. Prior to joining Vectura, Mr Meliniotis worked for Cambridge Design Partnership and The Technology Partnership, developing glucose measurement devices and industrial printing technology, respectively. He is a Chartered Mechanical Engineer and Chartered Manager and holds a bachelor’s degree in mechanical engineering from the University of Nottingham (UK). 📢 Andreas will present the topic "The evolution of a family of multi-dose DPIs" 👉 Request the Brochure now at https://rescon-europe.com/ #RESCON24 #RESCONEUROPE #Inhalation #Respiratory #drugdelivery #DPI

🌟 We are delighted to announce that Volker Dickfeld, Sr. Marketing Manager HealthCare Global at Avient Corporation, will be joining us as a speaker for RESCON Europe 2024 in Barcelona, Spain. 👨🔬 35 Year in the company. Various Sales, and Marketing Positions. Over 12 years abroad in Italy, France, China, and New Zealand. In the last 3-year Marketing responsible for Avient´s Mevopur Healthcare solutions. And always passioned about supporting customers to find solutions for their challenges in the plastics industry. 📢 Volker will present the topic "How a material supplier can help you achieve your sustainability goals for medical devices" 👉 Request the Brochure now at https://rescon-europe.com/ #RESCON24 #RESCONEUROPE #Inhalation #Respiratory #drugdelivery #sustainability #medicaldevices

✨ We are thrilled to announce the Silver Sponsor of our RESCON Europe 2024 in Barcelona, Spain: Inke 🏢 INKE is a developer and manufacturer of the highest quality active pharmaceutical ingredients (APIs) with complex synthesis processes, mainly for use in respiratory therapies. Visit: https://www.inke.es/ Thank you! Join us at https://rescon-europe.com/ #RESCON2024 #RESCONEUROPE #API #inhalation #respiratory

⭐ We are thrilled to announce that Dr. Nathalie Wauthoz, Associate Professor at ULB will be our speaker for the RESCON Europe 2024 in Barcelona, Spain! 👩🔬 Nathalie Wauthoz obtained her PharmD degree in 2006 at Université libre de Bruxelles (ULB). She obtained her PhD degree in Biomedical and Pharmaceutical sciences in 2011 under the supervision of Prof. K. Amighi in Laboratory of Pharmaceutics and Biopharmaceutics (LPB) at ULB. She performed several post-doctoral positions and one of them in the Prof. J.P. Benoit’s Mint unit, INSERM UMR-S 1066 (Angers, France). Since 2017, she is Associate Professor in LPB where she manages and develops the research projects in inhalation field. She had supervised/is supervising 10 PhD students until now. She has published more than 50 peer-reviewed papers in internationally recognized journals, more than 50 abstracts and conference proceedings and is co-inventor on 5 patents. She is also co-founder of the InhaTarget Therapeutics, a spin-off company of the ULB dedicated to the development of innovative dry powders for inhalation (DPIs). Her research focuses on the development of DPIs to combat different diseases (e.g. lung tumors, infectious diseases, asthma and COPD), and that with different dose (µg to tens of mg) and kind of drugs (e.g. poorly or freely water soluble – conventional or from biotechnologies), with optimal aerodynamic performance, lung retention and eventually increased cell or tumor penetration. Therefore, the formulations were evaluated in vitro on culture cells and in vivo on preclinical models. Nasal formulations for the nose to brain delivery of nucleic acids (e.g. siRNA) or peptide and proteins were also developed and evaluated in vitro on epithelial cell membrane and in vivo by histology and on preclinical models. 📢 At RESCON Europe 2024, Dr. Nathalie Wauthoz will be presenting on the topic of "Inhaled chemotherapy as a new modality to increase immunotherapy response in lung cancer therapy". 👉 Register now at https://rescon-europe.com/ #RESCON24 #RESCONEUROPE #drugdelivery #respiratory #inhalation #lungcancer #COPD #DPI

✨ We are thrilled to announce the Silver Sponsor of our RESCON Europe 2024 in Barcelona, Spain: Yirdoc 🏢 Yirdoc is a leading provider of customized mesh nebulizers for inhalation delivery needs. We focus on developing formulation-specific solutions and our mesh technology and digital platform are designed to improve clinical results and formulation development. As a trusted partner to pharmaceutical and biopharmaceutical companies, Yirdoc currently works with both small molecules and biologics to provide cost-effective solutions. Whether you’re looking to improve inhalation delivery or optimize inhalation clinical outcomes, Yirdoc has the expertise and technology to help you succeed. Visit: https://www.yirdoc.com/ Thank you! Join us at https://rescon-europe.com/ #RESCON2024 #RESCONEUROPE #sustainability #inhalation #respiratory #inhaler #drugdelivery #Nebulizer

⭐ We are thrilled to announce that Dr. Felix Weiland, Head of Device Technology at Boehringer Ingelheim microParts GmbH will be our speaker for the RESCON Europe 2024 in Barcelona, Spain! 👨🔬 Felix is a pharmacist by training with a PhD in pharmacology. In 2006, he joined Boehringer Ingelheim as a trainee, focusing on launch and transfer activities of inhalative products. He took over different roles at BI microParts for development of inhalation devices as QA Head, senior project manager and lab head for design engineering. In 2010, he joined the Ger-resheimer Group as a QC head and later on quality director for large-scale manufacturing of sterile primary packaging components, i.e.RTF®- syringes and insulin cartridges. In 2015, he returned to Boehringer Ingelheim to implement structures for life cycle management of the Respimat® Plat¬form Technology, including ownership of design history files for existing products and launching the new Respimat Reusable® in Europe in 2018. Currently he is the director of Device Technology in operations. He is responsible for a matrix organization that includes project management, design verification laboratories, clinical trial supply, design engineering, design control, process technology and data science approaches for life cycle of devices in operations. 📢 At RESCON Europe 2024, Felix will be presenting on the topic of "Respimat Soft Mist Inhaler – comparison with nebulizers". 👉 Register now at https://rescon-europe.com/ #RESCON24 #RESCONEUROPE #drugdelivery #respiratory #inhalation #SMI #Nebulizers

🌟 We are delighted to announce that Dr. Ronan Mac Loughlin PhD MBS, Director of R&D, Science and Emerging Technologies at Aerogen, will be joining us as a speaker for RESCON Europe 2024 in Barcelona, Spain. 👨🔬 Dr Ronan MacLoughlin, PhD, MBS is currently Director of R&D, Science and Emerging Technologies in Aerogen Limited. Dr MacLoughlin has more than 20 years’ experience in Respiratory Drug Delivery with several nebuliser, and accessory product launches over that time. He has responsibility for new product development, establishing and exploiting the science underpinning respiratory drug delivery and identifying new and potentially disruptive emerging technologies. To this end, he has developed multiple technologies and products with several patents granted and pending, that cover the range of drug, device, drug/device combination products, patient interventions, and patient interfaces. Of note, this includes the world’s first fit for purpose mass vaccination by inhalation delivery system, currently in use with Convidicia Air, the first approved inhaled COVID-19 vaccine. Dr MacLoughlin was also previously head of Medical Affairs in Aerogen. Dr MacLoughlin currently serves on (previously chair) the Industry Representative Group in CURAM, the Science Foundation Ireland center for the development the next generation of smart medical devices, and sits on the board, (previously chair) of the Medical and Engineering Technologies Center (MET), the Enterprise Ireland Technology Gateway. Additionally, he is currently chair of the Paediatric and Cystic Fibrosis working group within the International Society for Aerosols in Medicine (ISAM). He sits on the board of LEP Biomedical, a preclinical company focused on the development of novel implantable drug delivery systems for the treatment of glaucoma and other ophthalmic conditions. Finally, Dr MacLoughlin holds the position of adjunct Associate Professor in Trinity College Dublin (School of Pharmacy and Pharmaceutical Sciences), and Senior Honorary lecturer in the Royal College of Surgeons, Ireland (School of Pharmacy & Biomolecular Sciences). 📢 Dr MacLoughlin will present the topic "Enabling next generation therapeutics and prophylactics – inhaled gene therapies and vaccines" 👉 Request the Brochure now at https://rescon-europe.com/ #RESCON24 #RESCONEUROPE #Inhalation #Respiratory #drugdelivery

🚀🚀🚀 Limited Tickets Available! 🚀🚀🚀 ✨ Join us at RESCON Europe, a prestigious and highly anticipated event building on the success of its New York editions. Dedicated to Inhalation & Respiratory Drug Delivery and Connected Devices, it brings together leading experts from the pharmaceutical, biotechnology industry, and academia. 👉 https://rescon-europe.com/ ✨ Attend InjectaSummit, the premier event for professionals in the pharmaceutical, medical device, and healthcare sectors. Discover the latest advancements in pre-filled syringes, injectable drug devices, and parenteral systems. 👉 https://injectasummit.com/ Special thanks to our sponsors & partners: Avient Corporation, CREDENCE MEDSYSTEMS, INC. Berry Global, Inc., Vectura Group, Harro Höfliger, Catalent Pharma Solutions, Victrex, Yirdoc, Inke, Shenzhen Coincell Battery Co., LTD, MUNIT SA, Smithers, teamtechnik Group Don't miss out—secure your spot today! Diogo Lino Ribeiro, BioTech Pharma Summit